Sabby Management’s Atossa Therapeutics ATOS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,381	Closed	-$47.6K	–	94
2023 Q1	$47.6K	Sell	4,381 -9,217	-68%	-$103K	0.18%	73
2022 Q4	$108K	Sell	13,598 -13,862	-50%	-$159K	0.29%	67
2022 Q3	$343K	Sell	27,460 -7,527	-22%	-$109K	0.72%	49
2022 Q2	$572K	Buy	34,987 +10,849	+45%	+$171K	1.06%	45
2022 Q1	$453K	Buy	+24,138	New	+$490K	0.18%	64
2021 Q3	–	Sell	-69,732	Closed	-$4.06M	–	184
2021 Q2	$6.61M	Buy	69,732 +53,583	+332%	+$2.84M	1.43%	12
2021 Q1	$511K	Buy	+16,149	New	+$590K	0.38%	110
2019 Q1	–	Sell	-33,497	Closed	-$513K	–	86
2018 Q4	$513K	Buy	33,497 +2,494	+8%	+$49.3K	0.48%	51
2018 Q3	$814K	Buy	31,003 +8,286	+36%	+$271K	0.65%	61
2018 Q2	$750K	Buy	+22,717	New	+$1.22M	0.43%	70
2017 Q3	–	Sell	-1,617	Closed	-$150K	–	174
2017 Q2	$150K	Buy	+1,617	New	+$166K	0.07%	187